Europe — EMA
Olmesartanmedoxomil/Amlodipin Mylan (Olmesartan Medoxomil, Amlodipine)
GNH USA supplies Olmesartanmedoxomil/Amlodipin Mylan (Olmesartan), an ARB for hypertension and cardiovascular risk reduction.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxil, the active ingredient in Olmesartanmedoxomil/Amlodipin Mylan, is an Angiotensin II receptor blocker (ARB) presented as a strength/form for oral use. It treats hypertension and may be prescribed for adults requiring blood pressure control. GNH USA supplies Olmesartanmedoxomil/Amlodipin Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olmesartanmedoxomil/Amlodipin Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmesartan medoxil/amlodipine combines two antihypertensive agents that act on the renin‑angiotensin system and vascular smooth‑muscle tone.
- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure with reduced ejection fraction: assists in afterload reduction when used with standard heart‑failure therapy. - Chronic kidney disease with hypertension: helps slow progression of renal impairment by controlling blood pressure. - Post‑myocardial infarction hypertension: contributes to secondary prevention by maintaining target blood‑pressure levels. - Diabetic nephropathy with hypertension: supports renal protection through sustained blood‑pressure control.
What are the side effects of Olmesartan Medoxomil, Amlodipine?
Olmesartanmedoxomil/Amlodipin Mylan is associated with a range of adverse reactions that vary in frequency and severity.
Common Side Effects: - Headache: mild to moderate intensity, often transient. - Peripheral edema: swelling of ankles or lower legs, especially with amlodipine. - Dizziness or light‑headedness: related to blood‑pressure lowering. - Fatigue: general feeling of tiredness. - Flushing: warm sensation, usually mild.
Serious or Rare Side Effects: - Angio‑edema: rapid swelling of face, lips, tongue or airway requiring emergency care. - Hyperkalemia: elevated blood potassium levels, potentially dangerous. - Acute kidney injury: sudden decline in renal function, monitored by labs. - Hepatic dysfunction: abnormal liver enzymes indicating liver stress. - Severe hypotension: markedly low blood pressure causing syncope or shock.
What precautions apply to Olmesartan Medoxomil, Amlodipine?
When prescribing Olmesartanmedoxomil/Amlodipin Mylan, clinicians should consider several safety aspects.
- Renal function: assess baseline creatinine and monitor periodically. - Hepatic impairment: use with caution in patients with liver disease. - Electrolyte balance: watch for potassium abnormalities, especially with concomitant ARBs. - Pregnancy: avoid use; teratogenic risk is associated with ARBs. - Elderly patients: start at lower dose and titrate slowly. - Store at ambient temperature: keep below 25°C, protect from moisture and light in original packaging.
What does Olmesartan Medoxomil, Amlodipine interact with?
Olmesartanmedoxomil/Amlodipin Mylan can interact with several drug classes, altering its efficacy or safety profile.
Major Interactions (Avoid): - Dual renin‑angiotensin system blockade (e.g., ACE inhibitors, other ARBs): increased risk of hyperkalemia and renal impairment. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may raise amlodipine levels, leading to hypotension.
Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can blunt antihypertensive effect and affect renal function. - Diuretics: may potentiate hypotensive response, requiring dose adjustment. - Lithium: concurrent use can increase lithium concentrations, risking toxicity.
